-+ 0.00%
-+ 0.00%
-+ 0.00%

APOLLOMICS SHARES FALL 25% PREMARKET AFTER CO'S BLOOD CANCER DRUG FAILS TO MEET MAIN GOAL IN STUDY

Reuters·12/20/2024 13:50:28

Please log in to view news